Kegg medicus dgroup
| DG01283 | |
| DG番号 | DG01283 |
| 分類 | DGroup |
| 名称 | Teneligliptin TYPE Chemical |
| ステム | - |
| 構造式 |  |
| メンバー | D08616 Teneligliptin (INN) D09756 Teneligliptin hydrobromide hydrate (JAN) D11968 Teneligliptin hydrobromide (JAN) |
| 上位グループ | Antidiabetic agent DG02044 Hypoglycemic agent DG01601 DPP-4 inhibitor Metabolizing enzyme substrate DG01633 CYP3A/CYP3A4 substrate DG02913 CYP3A4 substrate DG03191 FMO1 substrate DG02950 FMO3 substrate Metabolizing enzyme inhibitor DG01645 CYP2D6 inhibitor DG02852 CYP3A/CYP3A4 inhibitor DG01522 CYP3A4 inhibitor DG02951 FMO inhibitor |
| 注釈1 | ATC code: A10BH08 |
| 注釈2 | - |